This statistic depicts the percentage of orphan and oncology drugs released in Canada and select other developed countries that were new active substances (NAS) from 2015 to 2021. According to the data, in 2021, 42 percent of approved new active substances received an orphan drug designation.
Share of orphan or oncology drugs among approved new active substances (NAS) in select developed countries from 2015 to 2021
Includes drugs launched in: Canada, Belgium, France, Germany, Italy, the Netherlands, Norway, Spain, Sweden, the
United Kingdom, and the United States.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
PMPRB. (August 1, 2023). Share of orphan or oncology drugs among approved new active substances (NAS) in select developed countries from 2015 to 2021 [Graph]. In Statista. Retrieved July 23, 2024, from https://www.statista.com/statistics/892120/new-active-substances-global-orphan-and-oncology-drugs/
PMPRB. "Share of orphan or oncology drugs among approved new active substances (NAS) in select developed countries from 2015 to 2021." Chart. August 1, 2023. Statista. Accessed July 23, 2024. https://www.statista.com/statistics/892120/new-active-substances-global-orphan-and-oncology-drugs/
PMPRB. (2023). Share of orphan or oncology drugs among approved new active substances (NAS) in select developed countries from 2015 to 2021. Statista. Statista Inc.. Accessed: July 23, 2024. https://www.statista.com/statistics/892120/new-active-substances-global-orphan-and-oncology-drugs/
PMPRB. "Share of Orphan or Oncology Drugs among Approved New Active Substances (Nas) in Select Developed Countries from 2015 to 2021." Statista, Statista Inc., 1 Aug 2023, https://www.statista.com/statistics/892120/new-active-substances-global-orphan-and-oncology-drugs/
PMPRB, Share of orphan or oncology drugs among approved new active substances (NAS) in select developed countries from 2015 to 2021 Statista, https://www.statista.com/statistics/892120/new-active-substances-global-orphan-and-oncology-drugs/ (last visited July 23, 2024)
Share of orphan or oncology drugs among approved new active substances (NAS) in select developed countries from 2015 to 2021 [Graph], PMPRB, August 1, 2023. [Online]. Available: https://www.statista.com/statistics/892120/new-active-substances-global-orphan-and-oncology-drugs/